Tabersonine

N/A

Report date: 2023/01/17 13:37:01

Base Information

Drug NameTabersonine
Drug Alias NameTab
ClassificationNatural product/Extract
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsAcute Lung InjurySepsisPeritonitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe First Affiliated Hospital Of Wenzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Wenzhou Medical University
Inactive CompaniesN/A
Active IndicationsAcute Lung InjurySepsisPeritonitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A